AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 811471 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mug TRH (single injection)
Number of subjects: 4
Study 811471 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mug TRH (six injections with 30 minutes interval)
Number of subjects: 4
Study 31927662 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention groups (n=244 bakers)
Number of subjects: 337
Study 29665158 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrointestinal delivery oral immunotherapy (GIDOIT) with peanut capsules, 2 to 400 mg of peanut protein daily for 24 weeks
Number of subjects: 30
Study 29665158 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 30
Study 29665158 — intervention group
Group type: EXPERIMENTAL
Intervention: GIDOIT
Number of subjects: 30
Study 26667929 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable resistance training
Number of subjects: 21
Study 26667929 — intervention group
Group type: COMPARATOR
Intervention: Unstable resistance training
Number of subjects: 21
Study 24445356 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K1 injection in the Spleen‐6 (SP‐6) acupuncture point
Number of subjects: 14
Study 24445356 — intervention group
Group type: COMPARATOR
Intervention: Saline injection in a nonacupuncture point
Number of subjects: 14
Study 24445356 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K1 injection
Number of subjects: 14
Study 24445356 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 14
Study 24445356 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection therapy
Number of subjects: 14
Study 22573418 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone interpersonal counseling (TIP-C)
Number of subjects: 140
Study 22573418 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone health education (THE)
Number of subjects: 140
Study 20855910 — intervention group
Group type: EXPERIMENTAL
Intervention: four-layer compression bandage
Number of subjects: 12
Study 20855910 — intervention group
Group type: COMPARATOR
Intervention: short-stretch compression bandage
Number of subjects: 12
Study 19025267 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette craving (hot state)
Number of subjects: 0
Study 19025267 — intervention group
Group type: COMPARATOR
Intervention: Satiated state (cold state)
Number of subjects: 0
Study 19025267 — intervention group
Group type: EXPERIMENTAL
Intervention: Hungry dieters (hot state)
Number of subjects: 0
Study 19025267 — intervention group
Group type: COMPARATOR
Intervention: Satiated dieters (cold state)
Number of subjects: 0
Study 16469108 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (dietary energy restriction and aerobic exercise training)
Number of subjects: 100
Study 16469108 — intervention group
Group type: COMPARATOR
Intervention: Normal care control group
Number of subjects: 100
Study 12566870 — intervention group
Group type: EXPERIMENTAL
Intervention: Timoptol XE
Number of subjects: 37
Study 12566870 — intervention group
Group type: EXPERIMENTAL
Intervention: Lizmon TG
Number of subjects: 37
Study 12566870 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Timoptol XE and Lizmon TG
Number of subjects: 37
Study 10646284 — intervention group
Group type: EXPERIMENTAL
Intervention: Inverse filtering (Kalman and Wiener filters) of the voice signal to estimate the residue and extract seven acoustic features.
Number of subjects: 0
Study 9543660 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic couples (female alcoholics with nonalcoholic spouses) in no-drink sessions
Number of subjects: 131
Study 9543660 — intervention group
Group type: EXPERIMENTAL
Intervention: Concordant couples (both spouses alcoholic)
Number of subjects: 131
Study 9543660 — intervention group
Group type: EXPERIMENTAL
Intervention: All alcoholic groups
Number of subjects: 131
Study 9543660 — intervention group
Group type: COMPARATOR
Intervention: Couples with male alcoholics
Number of subjects: 131
Study 8367870 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined perioperative infusion of nifedipine (10 micrograms/kg/h) and metoprolol (12 micrograms/kg/h)
Number of subjects: 70
Study 8367870 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine only
Number of subjects: 70
Study 3492644 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative electrical calf stimulation
Number of subjects: 0
Study 3492644 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression
Number of subjects: 0
Study 3492644 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated compression stockings
Number of subjects: 0
Study 3492644 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological methods
Number of subjects: 0
Study 2558882 — intervention group
Group type: EXPERIMENTAL
Intervention: Meals with added table salt (4.25 g)
Number of subjects: 10
Study 2558882 — intervention group
Group type: COMPARATOR
Intervention: Meals without added table salt
Number of subjects: 10
Study 31393628 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT)
Number of subjects: 12
Study 31268183 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based Healthy Body Image (HBI) Program
Number of subjects: 4894
Study 31268183 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening results
Number of subjects: 4894
Study 31268183 — intervention group
Group type: EXPERIMENTAL
Intervention: HBI Program
Number of subjects: 4894
Study 27467589 — intervention group
Group type: EXPERIMENTAL
Intervention: Valencia model of waking hypnosis plus cognitive‐behavioral therapy (VMWH‐CBT)
Number of subjects: 44
Study 27467589 — intervention group
Group type: COMPARATOR
Intervention: Education control intervention
Number of subjects: 44
Study 26050076 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent walking (three 2-minute walking bouts)
Number of subjects: 27
Study 26050076 — intervention group
Group type: COMPARATOR
Intervention: Continuous walking (6 uninterrupted minutes)
Number of subjects: 27
Study 23932862 — intervention group
Group type: EXPERIMENTAL
Intervention: Biolimus‐A9‐eluting stents (BES)
Number of subjects: 60
Study 23932862 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus‐eluting stents (SES)
Number of subjects: 60
Study 22144044 — intervention group
Group type: EXPERIMENTAL
Intervention: High-saturated fatty acid (HSFA) diet
Number of subjects: 0
Study 22144044 — intervention group
Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid (HMUFA) diet
Number of subjects: 0
Study 22144044 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat, high-complex carbohydrate diet supplemented with n-3 polyunsaturated fatty acids (LFHCC n-3)
Number of subjects: 0
Study 22144044 — intervention group
Group type: COMPARATOR
Intervention: Low-fat, high-complex carbohydrate diet supplemented with placebo (LFHCC)
Number of subjects: 0
Study 22144044 — intervention group
Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 0
Study 19656558 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of labour
Number of subjects: 756
Study 19656558 — intervention group
Group type: COMPARATOR
Intervention: Expectant monitoring
Number of subjects: 756
Study 16915107 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin administration (300 mL of 20% albumin solution on the first day, then 200 mL/day if serum albumin <31 g/dL)
Number of subjects: 100
Study 16915107 — intervention group
Group type: COMPARATOR
Intervention: Control group (no albumin administration)
Number of subjects: 100
Study 12419083 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal estradiol 150 microg/day
Number of subjects: 165
Study 12419083 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal estradiol 300 microg/day
Number of subjects: 165
Study 12419083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study 10599387 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin cream 0.1% applied every evening and hydroquinone lotion 3% applied every morning
Number of subjects: 0
Study 7782660 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive blood pressure measurement using NCAT N-500 (oscillometrically calibrated tonometric blood pressure)
Number of subjects: 15
Study 7782660 — intervention group
Group type: COMPARATOR
Intervention: Intra-arterial blood pressure (IBP) measurements
Number of subjects: 15
Study 1777832 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide, 200 micrograms once daily in each nostril
Number of subjects: 22
Study 1777832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 7471617 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol 200 micrograms
Number of subjects: 0
Study 7471617 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline 500 micrograms
Number of subjects: 0
Study 7471617 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31240995 — intervention group
Group type: EXPERIMENTAL
Intervention: BUD/FORM plus I+T (160/4.5 µg; two inhalations twice daily via Turbuhaler®) + I (20 µg per inhalation, two inhalations four times daily) + T (100 mg bid)
Number of subjects: 584
Study 31240995 — intervention group
Group type: EXPERIMENTAL
Intervention: BUD/FORM plus I+T
Number of subjects: 584
Study 31240995 — intervention group
Group type: COMPARATOR
Intervention: I+T alone
Number of subjects: 584
Study 28540802 — intervention group
Group type: EXPERIMENTAL
Intervention: Embolisation
Number of subjects: 73
Study 28540802 — intervention group
Group type: COMPARATOR
Intervention: Without embolisation
Number of subjects: 73
Study 26281342 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound infiltration with 4 mg of lornoxicam
Number of subjects: 80
Study 26281342 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 80
Study 23569014 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% ropivacaine
Number of subjects: 105
Study 23569014 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.14% ropivacaine
Number of subjects: 105
Study 23569014 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.16% ropivacaine
Number of subjects: 105
Study 23569014 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.18% ropivacaine
Number of subjects: 105
Study 23569014 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.20% ropivacaine
Number of subjects: 105
Study 23569014 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.22% ropivacaine
Number of subjects: 105
Study 23569014 — intervention group
Group type: COMPARATOR
Intervention: 0.50% ropivacaine
Number of subjects: 105
Study 22032053 — intervention group
Group type: EXPERIMENTAL
Intervention: Early atropine-dobutamine stress echocardiography (EA-DSE); atropine started at dobutamine infusion rate of 20 microg/kg/min, max dose 2.0 mg.
Number of subjects: 100
Study 22032053 — intervention group
Group type: COMPARATOR
Intervention: Conventional atropine-dobutamine stress echocardiography (CA-DSE);
Number of subjects: 100
Study 18617640 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic antiretroviral therapy
Number of subjects: 5472
Study 18617640 — intervention group
Group type: COMPARATOR
Intervention: Continuous antiretroviral therapy
Number of subjects: 5472
Study 18617640 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 5472
Study 18617640 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers on continuous HIV treatment
Number of subjects: 5472
Study 18617640 — intervention group
Group type: EXPERIMENTAL
Intervention: Past history of smoking
Number of subjects: 5472
Study 16598529 — intervention group
Group type: EXPERIMENTAL
Intervention: Method B (right heart catheterization-derived stroke volume)
Number of subjects: 20
Study 16598529 — intervention group
Group type: EXPERIMENTAL
Intervention: Method C (cardiovascular magnetic resonance-derived stroke volume)
Number of subjects: 20
Study 16598529 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods (B and C)
Number of subjects: 20
Study 12554989 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial cryoablation
Number of subjects: 279
Study 12554989 — intervention group
Group type: COMPARATOR
Intervention: Rollerball electroablation
Number of subjects: 279
Study 10927136 — intervention group
Group type: EXPERIMENTAL
Intervention: Pento+RT (Pentoxifylline + Radiotherapy)
Number of subjects: 47
Study 10927136 — intervention group
Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 47
Study 10927136 — intervention group
Group type: EXPERIMENTAL
Intervention: Pento+RT
Number of subjects: 47
Study 8617898 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric case-finding and liaison service
Number of subjects: 385
Study 1623866 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 8
Study 1623866 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrinone
Number of subjects: 8
Study 1623866 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 8
Study 1623866 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 8
Study 1623866 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostacyclin
Number of subjects: 8
Study 1623866 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydralazine
Number of subjects: 8
Study 1623866 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 8
Study 6241564 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral valve surgery with left atrial enlargement (Group B)
Number of subjects: 80
Study 6241564 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group A)
Number of subjects: 80
Study 30180779 — intervention group
Group type: EXPERIMENTAL
Intervention: HuCNS‐SC transplantation (40,000,000 cells)
Number of subjects: 12
Study 30180779 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 12
Study 30129426 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimotuzumab
Number of subjects: 0
Study 26987315 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified protocol combined with treatment-as-usual
Number of subjects: 54
Study 26987315 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list with treatment-as-usual
Number of subjects: 54
Study 25609654 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (10^9 cfu Bifobacterium bifidum A218, 10^9 cfu Bifobacterium catenulatum A302, 10^9 cfu Bifobacterium longum A101, 10^9 cfu Lactobacillus plantarum A87 daily for six months)
Number of subjects: 39
Study 25609654 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin capsules for six months)
Number of subjects: 39
Study 23532298 — intervention group
Group type: EXPERIMENTAL
Intervention: SMBG (n = 65)
Number of subjects: 195
Study 23532298 — intervention group
Group type: EXPERIMENTAL
Intervention: SMBG + supervised exercise (n = 65)
Number of subjects: 195
Study 23532298 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined SMBG groups (Ia + Ib)
Number of subjects: 195
Study 23532298 — intervention group
Group type: COMPARATOR
Intervention: Control group (HbA1c-based treatment, n = 65)
Number of subjects: 195
Study 19487059 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue-engineered bone grafts
Number of subjects: 35
Study 19487059 — intervention group
Group type: COMPARATOR
Intervention: Autologous bone
Number of subjects: 35
Study 18991077 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg oral micronized estradiol therapy
Number of subjects: 48
Study 18991077 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg oral micronized estradiol therapy
Number of subjects: 48
Study 18991077 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 16842669 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐6/‐572C/G genotype
Number of subjects: 505
Study 16842669 — intervention group
Group type: EXPERIMENTAL
Intervention: CG genotype
Number of subjects: 505
Study 16842669 — intervention group
Group type: EXPERIMENTAL
Intervention: GG genotype
Number of subjects: 505
Study 16842669 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐6/‐572 C/G polymorphism
Number of subjects: 505
Study 16842669 — intervention group
Group type: COMPARATOR
Intervention: Serum IL‐6 levels
Number of subjects: 505
Study 14640800 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohesive families
Number of subjects: 57
Study 14640800 — intervention group
Group type: EXPERIMENTAL
Intervention: Triangulated families
Number of subjects: 57
Study 14640800 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in family functioning
Number of subjects: 57
Study 14640800 — intervention group
Group type: EXPERIMENTAL
Intervention: Separate families
Number of subjects: 57
Study 11099596 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromolyn sodium
Number of subjects: 89
Study 11099596 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 89
Study 11099596 — intervention group
Group type: COMPARATOR
Intervention: Control (no therapy)
Number of subjects: 89
Study 11099596 — intervention group
Group type: EXPERIMENTAL
Intervention: Age over 12 months
Number of subjects: 89
Study 11099596 — intervention group
Group type: EXPERIMENTAL
Intervention: History of wheezing
Number of subjects: 89
Study 11099596 — intervention group
Group type: EXPERIMENTAL
Intervention: Atopic dermatitis on study entry
Number of subjects: 89
Study 11099596 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin prick test positivity at 16 months
Number of subjects: 89
Study 11099596 — intervention group
Group type: EXPERIMENTAL
Intervention: Furred pet sensitization
Number of subjects: 89
Study 11099596 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV identification
Number of subjects: 89
Study 11099596 — intervention group
Group type: EXPERIMENTAL
Intervention: Early furred pet contact at home
Number of subjects: 89
Study 9089901 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid supplementation (5.2 g of concentrated fish oil triglyceride, 1.60 g/day EPA and 1.04 g/day DHA)
Number of subjects: 28
Study 9089901 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5.2 g corn oil)
Number of subjects: 28
Study 9089901 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid supplementation
Number of subjects: 28
Study 9089901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 1610257 — intervention group
Group type: EXPERIMENTAL
Intervention: St. Jude mitral valve prosthesis
Number of subjects: 102
Study 1610257 — intervention group
Group type: COMPARATOR
Intervention: Medtronic-Hall mitral valve prosthesis
Number of subjects: 102
Study 1610257 — intervention group
Group type: EXPERIMENTAL
Intervention: Both prostheses
Number of subjects: 102
Study 3889758 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate intensive remission induction using Daunomycin and Cytosine Arabinoside (branch I)
Number of subjects: 27
Study 3889758 — intervention group
Group type: COMPARATOR
Intervention: Supportive care, 'wait and see' policy, and palliative cytoreduction with Hydroxyurea and Ara C when necessary (branch II)
Number of subjects: 27
Study 31160171 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib 600 mg/d (3 weeks on/1 week off) with letrozole 2.5 mg/d (continuous)
Number of subjects: 213
Study 31160171 — intervention group
Group type: COMPARATOR
Intervention: Placebo with letrozole
Number of subjects: 213
Study 31160171 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib
Number of subjects: 213
Study 31160171 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 29102285 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterectomy
Number of subjects: 13
Study 29102285 — intervention group
Group type: COMPARATOR
Intervention: Myectomy alone
Number of subjects: 13
Study 29102285 — intervention group
Group type: COMPARATOR
Intervention: Myectomy and foraminotomy/fasciotomy
Number of subjects: 13
Study 29102285 — intervention group
Group type: COMPARATOR
Intervention: Myectomy and arterectomy
Number of subjects: 13
Study 29102285 — intervention group
Group type: COMPARATOR
Intervention: Foraminotomy/fasciotomy alone
Number of subjects: 13
Study 26632082 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral dose of guaifenesin (age‐based doses of 100‐400 mg)
Number of subjects: 40
Study 24351572 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpreserved methylprednisolone 1% (group A)
Number of subjects: 68
Study 24351572 — intervention group
Group type: COMPARATOR
Intervention: Preserved prednisolone 1% (group B)
Number of subjects: 68
Study 22817381 — intervention group
Group type: EXPERIMENTAL
Intervention: Preprocedural ventricular rate during AF (lowest quartile)
Number of subjects: 102
Study 22817381 — intervention group
Group type: EXPERIMENTAL
Intervention: Low preprocedural ventricular rate during AF
Number of subjects: 102
Study 20013603 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum chewing (group G, N = 193)
Number of subjects: 388
Study 20013603 — intervention group
Group type: COMPARATOR
Intervention: Control group (group C, N = 195)
Number of subjects: 388
Study 18667293 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior therapy for 12 weeks
Number of subjects: 11
Study 18667293 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 11
Study 16248238 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Danshen Droplet‐pill (DS) combined with trimetazidine (TMZ)
Number of subjects: 120
Study 16248238 — intervention group
Group type: COMPARATOR
Intervention: Trimetazidine (TMZ) alone (Control group)
Number of subjects: 120
Study 12587807 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium bromide
Number of subjects: 0
Study 12587807 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium bromide
Number of subjects: 0
Study 10554442 — intervention group
Group type: EXPERIMENTAL
Intervention: Party blower intervention
Number of subjects: 80
Study 10554442 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinwheel intervention
Number of subjects: 80
Study 10554442 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard instructions)
Number of subjects: 80
Study 8277091 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulodexide (600 LRU intramuscular injection for 1 month, followed by 500 LRU oral capsules twice daily)
Number of subjects: 3986
Study 2657423 — intervention group
Group type: EXPERIMENTAL
Intervention: 42-day dexamethasone (n = 13)
Number of subjects: 36
Study 2657423 — intervention group
Group type: EXPERIMENTAL
Intervention: 18-day dexamethasone (n = 12)
Number of subjects: 36
Study 2657423 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 11)
Number of subjects: 36
Study 1187285 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg/kg oral dose of a new xanthone drug
Number of subjects: 0